PGDx Received FDA Clearance for its Genomic Cancer Diagnostic Kit
Further advancing the biotech industry in the Region, Baltimore City-based Personal Genome Diagnostics has received U.S. Food and Drug Administration (FDA) approval of its diagnostic kit called PGDx elio tissue complete. The kit is the first of its kind and is designed to provide genomic profiling of cancer to patients and oncologists. Founded by Johns Hopkins researchers, the company’s progress “shows how Baltimore’s breakthroughs can have a commercial path,” wrote Stephen Babcock for